Compound class:
Synthetic organic
Comment: eAmSPC 2593 is the lead from a new class of N-ethylene linked aminomethyl spectinomycins (eAmSPCs), discovered following modification of spectinomycin, and with promising antimycobacterial activity [2]. The structure is claimed in patent WO2015048692A1 filed by St. Jude Children's Research Hospital [1].
|
|
References |
1. Lee RE, Waidyarachchi SL, Bruhn DF, Liu J, Zheng Z, Rosch JW. (2015)
Aryl substituted aminomethyl spectinomycin analogs as antibacterial agents. Patent number: WO2015048692A1. Assignee: St. Jude Children's Research Hospital. Priority date: 29/09/2013. Publication date: 02/04/2015. |
2. Phelps GA, Cheramie MN, Fernando DM, Selchow P, Meyer CJ, Waidyarachchi SL, Dharuman S, Liu J, Meuli M, Molin MD et al.. (2024)
Development of 2nd generation aminomethyl spectinomycins that overcome native efflux in Mycobacterium abscessus. Proc Natl Acad Sci U S A, 121 (2): e2314101120. [PMID:38165935] |